Literature DB >> 21625387

The role of miR-103 and miR-107 in regulation of CDK5R1 expression and in cellular migration.

Silvia Moncini1, Alessandro Salvi, Paola Zuccotti, Gabriella Viero, Alessandro Quattrone, Sergio Barlati, Giuseppina De Petro, Marco Venturin, Paola Riva.   

Abstract

CDK5R1 encodes p35, a specific activator of the serine/threonine kinase CDK5, which plays crucial roles in CNS development and maintenance. CDK5 activity strongly depends on p35 levels and p35/CDK5 misregulation is deleterious for correct CNS function, suggesting that a tightly controlled regulation of CDK5R1 expression is needed for proper CDK5 activity. Accordingly, CDK5R1 expression was demonstrated to be controlled at both transcriptional and post-transcriptional levels, but a possible regulation through microRNAs (miRNAs) has never been investigated. We predicted, within the large CDK5R1 3'UTR several miRNA target sites. Among them, we selected for functional studies miR-103 and miR-107, whose expression has shown a strong inverse correlation with p35 levels in different cell lines. A significant reduction of CDK5R1 mRNA and p35 levels was observed after transfection of SK-N-BE neuroblastoma cells with the miR-103 or miR-107 precursor (pre-miR-103 or pre-miR-107). Conversely, p35 levels significantly increased following transfection of the corresponding antagonists (anti-miR-103 or anti-miR-107). Moreover, the level of CDK5R1 transcript shifts from the polysomal to the subpolysomal mRNA fraction after transfection with pre-miR-107 and, conversely, from the subpolysomal to the polysolmal mRNA fraction after transfection with anti-miR-107, suggesting a direct action on translation efficiency. We demonstrate, by means of luciferase assays, that miR-103 and miR-107 are able to directly interact with the CDK5R1 3'-UTR, in correspondence of a specific target site. Finally, miR-103 and miR-107 overexpression, as well as CDK5R1 silencing, caused a reduction in SK-N-BE migration ability, indicating that these miRNAs affect neuronal migration by modulating CDK5R1 expression. These findings indicate that miR-103 and miR-107 regulate CDK5R1 expression, allowing us to hypothesize that a miRNA-mediated mechanism may influence CDK5 activity and the associated molecular pathways.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21625387      PMCID: PMC3100319          DOI: 10.1371/journal.pone.0020038

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.240


  57 in total

1.  Mental retardation and cardiovascular malformations in NF1 microdeleted patients point to candidate genes in 17q11.2.

Authors:  M Venturin; P Guarnieri; F Natacci; M Stabile; R Tenconi; M Clementi; C Hernandez; P Thompson; M Upadhyaya; L Larizza; P Riva
Journal:  J Med Genet       Date:  2004-01       Impact factor: 6.318

2.  Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets.

Authors:  Benjamin P Lewis; Christopher B Burge; David P Bartel
Journal:  Cell       Date:  2005-01-14       Impact factor: 41.582

Review 3.  The neuronal microRNA system.

Authors:  Kenneth S Kosik
Journal:  Nat Rev Neurosci       Date:  2006-12       Impact factor: 34.870

4.  CRM 1-mediated degradation and agonist-induced down-regulation of beta-adrenergic receptor mRNAs.

Authors:  Ying Bai; Huafei Lu; Curtis A Machida
Journal:  Biochim Biophys Acta       Date:  2006-08-22

5.  Increased activity of cyclin-dependent kinase 5 leads to attenuation of cocaine-mediated dopamine signaling.

Authors:  Satoru Takahashi; Toshio Ohshima; Andrew Cho; Taduru Sreenath; Michael J Iadarola; Harish C Pant; Yong Kim; Angus C Nairn; Roscoe O Brady; Paul Greengard; Ashok B Kulkarni
Journal:  Proc Natl Acad Sci U S A       Date:  2005-01-21       Impact factor: 11.205

6.  MicroRNA responses to cellular stress.

Authors:  Carmen J Marsit; Karen Eddy; Karl T Kelsey
Journal:  Cancer Res       Date:  2006-11-15       Impact factor: 12.701

7.  A signature pattern of stress-responsive microRNAs that can evoke cardiac hypertrophy and heart failure.

Authors:  Eva van Rooij; Lillian B Sutherland; Ning Liu; Andrew H Williams; John McAnally; Robert D Gerard; James A Richardson; Eric N Olson
Journal:  Proc Natl Acad Sci U S A       Date:  2006-11-15       Impact factor: 11.205

8.  Decoy mRNAs reduce beta-amyloid precursor protein mRNA in neuronal cells.

Authors:  Pamela R Westmark; Hyun C Shin; Cara J Westmark; Syrus R Soltaninassab; Emily K Reinke; James S Malter
Journal:  Neurobiol Aging       Date:  2006-05-02       Impact factor: 4.673

Review 9.  A decade of CDK5.

Authors:  R Dhavan; L H Tsai
Journal:  Nat Rev Mol Cell Biol       Date:  2001-10       Impact factor: 94.444

10.  MicroRNA-23b mediates urokinase and c-met downmodulation and a decreased migration of human hepatocellular carcinoma cells.

Authors:  Alessandro Salvi; Cristiano Sabelli; Silvia Moncini; Marco Venturin; Bruna Arici; Paola Riva; Nazario Portolani; Stefano M Giulini; Giuseppina De Petro; Sergio Barlati
Journal:  FEBS J       Date:  2009-04-16       Impact factor: 5.542

View more
  54 in total

1.  Differential expression of microRNAs associated with thermal stress in Frieswal (Bos taurus x Bos indicus) crossbred dairy cattle.

Authors:  Gyanendra Singh Sengar; Rajib Deb; Umesh Singh; T V Raja; Rajiv Kant; Basavraj Sajjanar; Rani Alex; R R Alyethodi; Ashish Kumar; Sushil Kumar; Rani Singh; Subhash J Jakhesara; C G Joshi
Journal:  Cell Stress Chaperones       Date:  2017-08-03       Impact factor: 3.667

2.  Human CYP2C8 is post-transcriptionally regulated by microRNAs 103 and 107 in human liver.

Authors:  Shu-Yun Zhang; Sailesh Surapureddi; Sherry Coulter; Stephen S Ferguson; Joyce A Goldstein
Journal:  Mol Pharmacol       Date:  2012-06-20       Impact factor: 4.436

Review 3.  The role of genetic and epigenetic alterations in neuroblastoma disease pathogenesis.

Authors:  Raquel Domingo-Fernandez; Karen Watters; Olga Piskareva; Raymond L Stallings; Isabella Bray
Journal:  Pediatr Surg Int       Date:  2012-12-29       Impact factor: 1.827

4.  MiRNA-107 inhibits proliferation and migration by targeting CDK8 in breast cancer.

Authors:  Xiao-Yu Li; Qi-Feng Luo; Chuan-Kui Wei; Deng-Feng Li; Jia Li; Lin Fang
Journal:  Int J Clin Exp Med       Date:  2014-01-15

5.  DINGO: differential network analysis in genomics.

Authors:  Min Jin Ha; Veerabhadran Baladandayuthapani; Kim-Anh Do
Journal:  Bioinformatics       Date:  2015-07-06       Impact factor: 6.937

6.  MicroRNA-107 inhibits glioma cell migration and invasion by modulating Notch2 expression.

Authors:  Lei Chen; Xiang-Rong Chen; Run Zhang; Peng Li; Yi Liu; Ke Yan; Xiao-Dan Jiang
Journal:  J Neurooncol       Date:  2013-01-09       Impact factor: 4.130

7.  Identification of unique MEK-dependent genes in GNAQ mutant uveal melanoma involved in cell growth, tumor cell invasion, and MEK resistance.

Authors:  Grazia Ambrosini; Christine A Pratilas; Li-Xuan Qin; Madhavi Tadi; Oliver Surriga; Richard D Carvajal; Gary K Schwartz
Journal:  Clin Cancer Res       Date:  2012-05-01       Impact factor: 12.531

8.  The microRNA miR-199a-5p down-regulation switches on wound angiogenesis by derepressing the v-ets erythroblastosis virus E26 oncogene homolog 1-matrix metalloproteinase-1 pathway.

Authors:  Yuk Cheung Chan; Sashwati Roy; Yue Huang; Savita Khanna; Chandan K Sen
Journal:  J Biol Chem       Date:  2012-10-11       Impact factor: 5.157

9.  Functional characterization of CDK5 and CDK5R1 mutations identified in patients with non-syndromic intellectual disability.

Authors:  Silvia Moncini; Paola Castronovo; Alessandra Murgia; Silvia Russo; Maria Francesca Bedeschi; Marta Lunghi; Angelo Selicorni; Maria Teresa Bonati; Paola Riva; Marco Venturin
Journal:  J Hum Genet       Date:  2015-12-10       Impact factor: 3.172

Review 10.  Cdk5 activity in the brain - multiple paths of regulation.

Authors:  Kavita Shah; Debomoy K Lahiri
Journal:  J Cell Sci       Date:  2014-06-01       Impact factor: 5.285

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.